This report aims to provide a comprehensive presentation of the global market for End-Stage Kidney Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End-Stage Kidney Disease Treatment. This report contains market size and forecasts of End-Stage Kidney Disease Treatment in global, including the following market information:
Global End-Stage Kidney Disease Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global End-Stage Kidney Disease Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
MK-3866 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of End-Stage Kidney Disease Treatment include BLR Bio LLC, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the End-Stage Kidney Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End-Stage Kidney Disease Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global End-Stage Kidney Disease Treatment Market Segment Percentages, by Type, 2022 (%)
MK-3866
Pacritinib
Sanguinate
Tesidolumab
Others
Global End-Stage Kidney Disease Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global End-Stage Kidney Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global End-Stage Kidney Disease Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global End-Stage Kidney Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End-Stage Kidney Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies End-Stage Kidney Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BLR Bio LLC
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of End-Stage Kidney Disease Treatment, market overview.
Chapter 2: Global End-Stage Kidney Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of End-Stage Kidney Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of End-Stage Kidney Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 End-Stage Kidney Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global End-Stage Kidney Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global End-Stage Kidney Disease Treatment Overall Market Size
2.1 Global End-Stage Kidney Disease Treatment Market Size: 2022 VS 2030
2.2 Global End-Stage Kidney Disease Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top End-Stage Kidney Disease Treatment Players in Global Market
3.2 Top Global End-Stage Kidney Disease Treatment Companies Ranked by Revenue
3.3 Global End-Stage Kidney Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 End-Stage Kidney Disease Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies End-Stage Kidney Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 End-Stage Kidney Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 End-Stage Kidney Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 End-Stage Kidney Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global End-Stage Kidney Disease Treatment Market Size Markets, 2022 & 2030
4.1.2 MK-3866
4.1.3 Pacritinib
4.1.4 Sanguinate
4.1.5 Tesidolumab
4.1.6 Others
4.2 By Type - Global End-Stage Kidney Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global End-Stage Kidney Disease Treatment Revenue, 2018-2023
4.2.2 By Type - Global End-Stage Kidney Disease Treatment Revenue, 2024-2030
4.2.3 By Type - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global End-Stage Kidney Disease Treatment Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global End-Stage Kidney Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global End-Stage Kidney Disease Treatment Revenue, 2018-2023
5.2.2 By Application - Global End-Stage Kidney Disease Treatment Revenue, 2024-2030
5.2.3 By Application - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global End-Stage Kidney Disease Treatment Market Size, 2022 & 2030
6.2 By Region - Global End-Stage Kidney Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global End-Stage Kidney Disease Treatment Revenue, 2018-2023
6.2.2 By Region - Global End-Stage Kidney Disease Treatment Revenue, 2024-2030
6.2.3 By Region - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America End-Stage Kidney Disease Treatment Revenue, 2018-2030
6.3.2 US End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.3.3 Canada End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.3.4 Mexico End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe End-Stage Kidney Disease Treatment Revenue, 2018-2030
6.4.2 Germany End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.3 France End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.4 U.K. End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.5 Italy End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.6 Russia End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.7 Nordic Countries End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.4.8 Benelux End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia End-Stage Kidney Disease Treatment Revenue, 2018-2030
6.5.2 China End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.5.3 Japan End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.5.4 South Korea End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.5.5 Southeast Asia End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.5.6 India End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America End-Stage Kidney Disease Treatment Revenue, 2018-2030
6.6.2 Brazil End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.6.3 Argentina End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa End-Stage Kidney Disease Treatment Revenue, 2018-2030
6.7.2 Turkey End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.7.3 Israel End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia End-Stage Kidney Disease Treatment Market Size, 2018-2030
6.7.5 UAE End-Stage Kidney Disease Treatment Market Size, 2018-2030
7 End-Stage Kidney Disease Treatment Companies Profiles
7.1 BLR Bio LLC
7.1.1 BLR Bio LLC Company Summary
7.1.2 BLR Bio LLC Business Overview
7.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Major Product Offerings
7.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.1.5 BLR Bio LLC Key News & Latest Developments
7.2 CTI BioPharma Corp
7.2.1 CTI BioPharma Corp Company Summary
7.2.2 CTI BioPharma Corp Business Overview
7.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Major Product Offerings
7.2.4 CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.2.5 CTI BioPharma Corp Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG End-Stage Kidney Disease Treatment Major Product Offerings
7.4.4 Novartis AG End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Prolong Pharmaceuticals LLC
7.5.1 Prolong Pharmaceuticals LLC Company Summary
7.5.2 Prolong Pharmaceuticals LLC Business Overview
7.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Major Product Offerings
7.5.4 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.5.5 Prolong Pharmaceuticals LLC Key News & Latest Developments
7.6 VESSL Therapeutics Ltd
7.6.1 VESSL Therapeutics Ltd Company Summary
7.6.2 VESSL Therapeutics Ltd Business Overview
7.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Major Product Offerings
7.6.4 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue in Global Market (2018-2023)
7.6.5 VESSL Therapeutics Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. End-Stage Kidney Disease Treatment Market Opportunities & Trends in Global Market
Table 2. End-Stage Kidney Disease Treatment Market Drivers in Global Market
Table 3. End-Stage Kidney Disease Treatment Market Restraints in Global Market
Table 4. Key Players of End-Stage Kidney Disease Treatment in Global Market
Table 5. Top End-Stage Kidney Disease Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global End-Stage Kidney Disease Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global End-Stage Kidney Disease Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies End-Stage Kidney Disease Treatment Product Type
Table 9. List of Global Tier 1 End-Stage Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 End-Stage Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - End-Stage Kidney Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - End-Stage Kidney Disease Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - End-Stage Kidney Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - End-Stage Kidney Disease Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global End-Stage Kidney Disease Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global End-Stage Kidney Disease Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 30. BLR Bio LLC Company Summary
Table 31. BLR Bio LLC End-Stage Kidney Disease Treatment Product Offerings
Table 32. BLR Bio LLC End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. BLR Bio LLC Key News & Latest Developments
Table 34. CTI BioPharma Corp Company Summary
Table 35. CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Offerings
Table 36. CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. CTI BioPharma Corp Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Offerings
Table 40. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. Novartis AG Company Summary
Table 43. Novartis AG End-Stage Kidney Disease Treatment Product Offerings
Table 44. Novartis AG End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis AG Key News & Latest Developments
Table 46. Prolong Pharmaceuticals LLC Company Summary
Table 47. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Offerings
Table 48. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Prolong Pharmaceuticals LLC Key News & Latest Developments
Table 50. VESSL Therapeutics Ltd Company Summary
Table 51. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Offerings
Table 52. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. VESSL Therapeutics Ltd Key News & Latest Developments
List of Figures
Figure 1. End-Stage Kidney Disease Treatment Segment by Type in 2022
Figure 2. End-Stage Kidney Disease Treatment Segment by Application in 2022
Figure 3. Global End-Stage Kidney Disease Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global End-Stage Kidney Disease Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global End-Stage Kidney Disease Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by End-Stage Kidney Disease Treatment Revenue in 2022
Figure 8. By Type - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 16. US End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 20. Germany End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 28. China End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa End-Stage Kidney Disease Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE End-Stage Kidney Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. BLR Bio LLC End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis AG End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
